Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 129-136

  Caiazzo, Gianluca ^a,b   Kilic, Ismail Dogu ^b   Fabris, Enrico ^b,e   Serdoz, Roberta ^b   Mattesini, Alessio ^c   Foin, Nicolas ^d   De Rosa, Salvatore ^a   Indolfi, Ciro ^a   Di Mario, Carlo ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Department of Heart and Vessels AOUC Careggi ^*  (Italy)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Abbreviations ACS acute coronary syndrome; BVS bioresorbable vascular scaffold; DES drug eluting stent; MACE major adverse cardiovascular events; MI myocardial infarction; ST stent Scaffold Thrombosis; TLF target lesion failure; TLR target lesion revascularization; TVF target vessel failure; TVR target vessel revascularization

Indexed keywords

BIORESORBABLE SCAFFOLD; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; DRUG ELUTING STENT; HUMAN; IN STENT LATE LUMEN LOSS; INTRAVASCULAR ULTRASOUND; MEDICAL DEVICE COMPLICATION; METAL STENT; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; REVIEW; SCAFFOLD THROMBOSIS; STENT MALAPPOSITION; THROMBOSIS; ANIMAL; BIODEGRADABLE IMPLANT; BLOOD VESSEL PROSTHESIS; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; PROCEDURES; PROSTHESIS DESIGN; TIME FACTOR; TISSUE SCAFFOLD; TREATMENT OUTCOME; TRENDS;

ABSORBABLE IMPLANTS; ANIMALS; BLOOD VESSEL PROSTHESIS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; HUMANS; PROSTHESIS DESIGN; TIME FACTORS; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84943517234     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.101     Document Type: Review

References (61)

1. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 7 2011 779 797
2. J.A. Ormiston, P.W. Serruys, E. Regar, and et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 9616 2008 899 907
3. P.W. Serruys, J.A. Ormiston, Y. Onuma, and et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 9667 2009 897 910
4. P.W. Serruys, H.M. Garcia-Garcia, and Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade Eur. Heart J. 33 1 2012 16-25b
5. R.P. Kraak, M.E. Hassell, M.J. Grundeken, and et al. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC single centre real world PCI registry EuroIntervention Aug 20 2014 10.4244/EIJY14M08-08 ([Epub ahead of print], pii: 20140316-04)
6. D. Capodanno, T. Gori, H. Nef, and et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry EuroIntervention 10 10 2015 1144 1153
7. V. Kočka, M. Mal, P. Toušek, and et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19' Eur. Heart J. 35 12 2014 787 794
8. T. Gori, E. Schulz, U. Hink, and et al. Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes EuroIntervention 9 9 2014 1036 1041
9. P.W. Serruys, B. Chevalier, D. Dudek, and et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 9962 Jan 3 2015 43 54
10. P.W. Serruys, Y. Onuma, J.A. Ormiston, and et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 22 2010 2301 2312
11. Y.J. Zhang, C.V. Bourantas, T. Muramatsu, and et al. Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial EuroIntervention 10 6 2014 672 680
12. S. Tanimoto, P.W. Serruys, L. Thuesen, and et al. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials Catheter. Cardiovasc. Interv. 70 4 2007 515 523
13. J. Gomez-Lara, H.M. Garcia-Garcia, Y. Onuma, and et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents JACC Cardiovasc. Interv. 3 11 2010 1190 1198
14. P.W. Serruys, Y. Onuma, H.M. Garcia-Garcia, and et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months EuroIntervention 9 11 2014 1271 1284
15. P.W. Serruys, H.E. Luijten, K.J. Beatt, and et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months Circulation 77 2 1988 361 371
16. W.J. Ciccone II, C. Motz, C. Bentley, and J.P. Tasto Bioabsorbable implants in orthopaedics: new developments and clinical applications J. Am. Acad. Orthop. Surg. 9 5 2001 280 288
17. Y. Onuma, P.W. Serruys, L.E. Perkins, and et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 22 2010 2288 2300
18. Y. Onuma, D. Dudek, L. Thuesen, and et al. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial JACC Cardiovasc. Interv. 6 10 2013 999 1009
19. A. Abizaid, J.R. Costa Jr., A.L. Bartorelli, and et al. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled EuroIntervention 10 12 2015 1396 1401 (Apr)
20. C. Simsek, M. Magro, Y. Onuma, and et al. Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the bioresorbable vascular scaffold evaluated at Rotterdam cardiology hospitals (B-SEARCH) EuroIntervention 10 2 2014 236 240
21. S.H. Kang, K.W. Park, D.Y. Kang, and et al. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis Eur. Heart J. 35 2014 1147 1158
22. C. Costopoulos, A. Latib, T. Naganuma, and et al. Comparison of early clinical outcomes between Absorb bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population Catheter. Cardiovasc. Interv. 85 1 2015 E10 E15
23. A. Mattesini, G.G. Secco, G. Dall'Ara, and et al. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance JACC Cardiovasc. Interv. 7 7 2014 741 750
24. J. Wöhrle, C. Naber, T. Schmitz, and et al. Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds EuroIntervention 11 2 2015 149 156
25. L. Rzeszutko, Z. Siudak, A. Włodarczak, and et al. Contemporary use of bioresorbable vascular scaffolds (BVS) in patients with stable angina and acute coronary syndromes. Polish National Registry Kardiol. Pol. Jul 8 2014 10.5603/KP.a2014.0147 (Epub ahead of print)
26. R. Diletti, A. Karanasos, T. Muramatsu, and et al. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study Eur. Heart J. 35 12 2014 777 786
27. G.W. Stone, A. Abizaid, S. Silber, and et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: the MASTER trial J. Am. Coll. Cardiol. 60 2012 1975 1984
28. T. Kajiya, M. Liang, R.K. Sharma, and et al. Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI) EuroIntervention 9 4 2013 501 504
29. J. Wiebe, H. Möllmann, A. Most, and et al. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold Clin. Res. Cardiol. 103 2 2014 141 148
30. D. Arroyo, M. Togni, S. Puricel, and et al. Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial Trials 15 2014 9 10.1186/1745-6215-15-9
31. B.D. Gogas, P.W. Serruys, R. Diletti, and et al. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial JACC Cardiovasc. Interv. 5 6 2012 656 665
32. C. Indolfi, A. Mongiardo, C. Spaccarotella, G. Caiazzo, D. Torella, and S. De Rosa Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation Circ Cardiovasc. Imaging 7 4 2014 755 757
33. A. Ielasi, B. Cortese, A. Varricchio, and et al. Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry) EuroIntervention 11 2 2015 157 162
34. D. Dudek, Ł. Rzeszutko, W. Zasada, R. Depukat, Z. Siudak, A. Ochała, W. Wojakowski, T. Przewłocki, K. Żmudka, J. Kochman, A. Lekston, and M. Gąsior Bioresorbable vascular scaffolds in patients with acute coronary syndromes: the POLAR ACS study Pol. Arch. Med. Wewn. 124 12 2014 669 677
35. A.J. Brown, L.M. McCormick, D.M. Braganza, M.R. Bennett, S.P. Hoole, and N.E. West Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation Catheter. Cardiovasc. Interv. 84 1 2014 37 45
36. G. Görge, M. Haude, J. Ge, and et al. Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation J. Am. Coll. Cardiol. 26 3 1995 725 730
37. S.H. Hur, K. Kitamura, Y. Morino, and et al. Efficacy of postdeployment balloon dilatation for current generation stents as assessed by intravascular ultrasound Am. J. Cardiol. 88 10 2001 1114 1119
38. H. Doi, A. Maehara, G.S. Mintz, and et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials JACC Cardiovasc. Interv. 2 12 2009 1269 1275
39. S. Sonoda, Y. Morino, J. Ako, SIRIUS Investigators, and et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial J. Am. Coll. Cardiol. 43 11 2004 1959 1963
40. K. Fujii, S.G. Carlier, G.S. Mintz, and et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol. 45 7 2005 995 998
41. A. Latib, L. Ferri, A. Ielasi, and et al. Clinical outcomes after unrestricted implantation of everolimus-eluting stents JACC Cardiovasc. Interv. 2 12 2009 1219 1226
42. C. Di Mario, and G. Caiazzo Biodegradable stents: the golden future of angioplasty? Lancet 385 9962 2015 10 12
43. A. Chieffo, A. Latib, C. Caussin, and et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial Am. Heart J. 165 1 2013 65 72
44. P. Roy, D.H. Steinberg, S.J. Sushinsky, and et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents Eur. Heart J. 29 15 2008 1851 1857
45. B.E. Claessen, R. Mehran, G.S. Mintz, and et al. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents JACC Cardiovasc. Interv. 4 9 2011 974 981
46. Erratum in: JACC Cardiovasc. Interv. 4 11 2011 1255
47. H. Mudra, C. di Mario, P. de Jaegere, OPTICUS (OPTimization with ICUS to reduce stent restenosis) Study Investigators, and et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study) Circulation 104 12 2001 1343 1349
48. J. Gómez-Lara, S. Brugaletta, R. Diletti, and et al. Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold Catheter. Cardiovasc. Interv. 79 6 2012 890 902
49. R. Waksman, H. Kitabata, F. Prati, M. Albertucci, and G.S. Mintz Intravascular ultrasound versus optical coherence tomography guidance J. Am. Coll. Cardiol. 62 17 Suppl. 2013 S32 S40
50. F. Prati, L. Di Vito, G. Biondi-Zoccai, and et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study EuroIntervention 8 7 2012 823 829
51. J. Gomez-Lara, R. Diletti, S. Brugaletta, and et al. Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study EuroIntervention 8 2 2012 214 224
52. U.K. Allahwala, J.A. Cockburn, E. Shaw, G.A. Figtree, P.S. Hansen, and R. Bhindi Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention EuroIntervention 10 10 2015 1154 1159 (Feb)
53. G.J. Tearney, E. Regar, T. Akasaka, International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT), and et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J. Am. Coll. Cardiol. 59 12 2012 1058 1072
54. T. Yamaguchi, M. Terashima, T. Akasaka, and et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting Am. J. Cardiol. 101 5 2008 562 567
55. N. Gonzalo, P.W. Serruys, H.M. García-García, and et al. Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries Rev. Esp. Cardiol. 62 6 2009 615 624
56. J.L. Gutiérrez-Chico, F. Gijsen, E. Regar, and et al. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process JACC Cardiovasc. Interv. 5 4 2012 428 435
57. A. Karanasos, C. Simsek, M. Gnanadesigan, and et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold J. Am. Coll. Cardiol. 64 22 2014 2343 2356
58. N. Foin, M. Ghione, A. Mattesini, J.E. Davies, and C. Di Mario Bioabsorbable scaffold optimization in provisional stenting: insight from optical coherence tomography Eur. Heart J. Cardiovasc. Imaging 14 12 2013 1149
59. E. Alegría-Barrero, N. Foin, P.H. Chan, and et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters EuroIntervention 8 2 2012 205 213
60. B. Vaquerizo, A. Barros, S. Pujadas, E. Bajo, D. Estrada, F. Miranda-Guardiola, J. Rigla, M. Jiménez, J. Cinca, and A. Serra Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study EuroIntervention 11 5 2015 555 563
61. C. Di Mario, J. Bartunek, J. Bonnier, and et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial Lancet 369 2007 1869 1875